BioSpace News Archive

Rising prevalence of cancer and increasing initiatives by governments and healthcare organizations to raise cancer awareness are predicted to fuel market growth.

Increasing focus on personalized medicines and technological advancements in radiotracers will drive market growth.

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 2021 Raymond James Human Health Innovation Conference.

Cellectis S.A., a clinical-stage biotechnological company employing its core proprietary technologies to develop products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells in the field of immuno-oncology and gene-edited hematopoietic stem cells in other therapeutic indications, featured the Cellectis Innovation Days, a company event held on May 24-28, virtually.

Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today announced the appointment of three senior biopharmaceutical leaders to its Board of Directors: Ameet Mallik, Chief Executive Officer of Rafael Holdings; Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc., (NASDAQ GS: MRNA); and Mark McCamish, M.D., Ph.D.,

Increasing demand for point-of-care testing, rising prevalence of obesity and lifestyle disorders, and growing need for bedside glucose monitoring are key factors driving market growth.

Rising prevalence of infectious, animal-borne diseases including rabies and growing volume of rabies diagnostic tests expected to fuel market growth.

LifeStance Health Group, Inc. (“LifeStance Health” or the “Company”), one of the nation’s largest providers of outpatient mental health care, today announced the closing of its initial public offering of 40,000,000 shares of its common stock at a public offering price of $18.00 per share.

Acerus Pharmaceuticals Corporation announced the voting results from its annual meeting of shareholders held on June 14, 2021 in Toronto, Ontario.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.